CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) Twelve Months Ended October 31, Percent 2002 2001 Inc/(Dec) Orders $ 6,013 $ 6,414 (6%) Net revenue $ 6,010 $ 8,396 (28%) Costs and expenses: Cost of products and services 3,694 4,890 (24%) Research and development 1,169 1,280 (9%) Selling, general and administrative 2,754 3,004 (8%) Total costs and expenses 7,617 9,174 (17%) Loss from operations (1,607) (778) (107%) Other income (expense), net 60 301 (80%) Loss from continuing operations before taxes (1,547) (477) (224%) Benefit for taxes (525) (71) 639% Loss from continuing operations (1,022) (406) (152%) Earnings from discontinued operations (net of taxes) - 6 N/M (Loss) gain from sale of discontinued operations (net of taxes) (10) 646 (102%) (Loss) earnings before cumulative effect of accounting changes (1,032) 246 N/M Cumulative effect of adopting SFAS No. 133 (net of tax benefit of $16 million) - (25) N/M Cumulative effect of adopting SAB 101 (net of tax benefit of $27 million) - (47) N/M Net (loss) earnings $ (1,032) $ 174 N/M Net (loss) earnings per share - Basic and diluted: Loss from continuing operations $ (2.20) $ (0.89) Earnings from discontinued operations, net - 0.01 (Loss) gain from sale of discontinued operations, net (0.02) 1.41 Cumulative effect of adopting SFAS No. 133, net - (0.05) Cumulative effect of adopting SAB 101, net - (0.10) Net (loss) earnings $ (2.22) $ 0.38 Average shares used in computing net (loss) earnings per share: Basic and Diluted 465 458 Earnings from discontinued operations (net of taxes) and (Loss) gain from sale of discontinued operations (net of taxes) relate to the sale of our Healthcare Solutions group.
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) Three Months Ended October 31, Percent 2002 2001 Inc/(Dec) Orders $ 1,495 $ 1,221 22% Net revenue $ 1,736 $ 1,606 8% Costs and expenses: Cost of products and services 1,116 1,240 (10%) Research and development 299 324 (8%) Selling, general and administrative 708 734 (4%) Total costs and expenses 2,123 2,298 (8%) Loss from operations before taxes (387) (692) 44% Other income (expense), net 13 (11) 218% Loss from continuing operations before taxes (374) (703) 47% Benefit for taxes (139) (254) (45%) Loss from continuing operations (235) (449) 48% (Loss) gain from sale of discontinued operations (net of taxes) (1) 646 N/M Net (loss) earnings $ (236) $ 197 (220%) Net (loss) earnings per share - Basic and diluted: Loss from continuing operations $ (0.51) $ (0.98) Gain from sale of discontinued operations, net - 1.41 Net (loss) earnings $ (0.51) $ 0.43 Average shares used in computing net (loss) earnings per share: Basic and Diluted 467 460 (Loss) gain from sale of discontinued operations (net of taxes) relate to the sale of our Healthcare Solutions group.
PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Excluding Amortization of Goodwill and Other Intangibles, Acquisition and Divestitures Related Items and Other One-Time and Non-recurring Items (In millions, except per share amounts) Twelve Months Ended October 31, Percent 2002 2001 Inc/(Dec) Orders $ 6,013 $ 6,414 (6%) Net revenue $ 6,010 $ 8,396 (28%) Costs and expenses: Cost of products and services 3,447 4,790 (28%) Research and development 1,114 1,254 (11%) Selling, general and administrative 2,204 2,558 (14%) Total costs and expenses 6,765 8,602 (21%) Loss from operations (755) (206) (267%) Other income (expense), net 57 2 N/M Loss before taxes (698) (204) (242%) Benefit for taxes (307) (78) 294% Pro forma net loss $ (391) $ (126) (210%) Pro forma net loss per share: Basic $ (0.84) $ (0.28) Diluted $ (0.84) $ (0.28) Average shares used in computing pro forma net loss per share: Basic 465 458 Diluted 465 458 The above pro forma condensed consolidated statement of operations has been adjusted to exclude the following one-time and non-recurring items and reconcile to GAAP net (loss) earnings: Net (loss) earnings per GAAP $ (1,032) $ 174 Pro forma adjustments: Goodwill 326 303 Other intangibles (including in-process R&D) 52 41 Restructuring 474 154 Gain on sale of assets (13) (269) SFAS No. 133 adoption - 41 SAB 101 adoption - 74 Gain relating to securities - (38) Discontinued operations 16 (1,089) Capitalized software write-off - 74 Other asset impairment 24 8 Retirement plans curtailment gain (19) - Other 6 - Adjustment for income taxes (225) 401 Pro forma net loss $ (391) $ (126) We provide pro forma financial information to help the reader better understand our operating results. This information is not in accordance with, or an alternative for, generally accepted accounting principles and may be different from the pro forma information provided by other companies.
PRO FORMA CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS Excluding Amortization of Goodwill and Other Intangibles, Acquisition and Divestitures Related Items and Other One-Time and Non-recurring Items (In millions, except per share amounts) Three Months Ended October 31, Percent 2002 2001 Inc/(Dec) Orders $ 1,495 $ 1,221 22% Net revenue $ 1,736 $ 1,606 8% Costs and expenses: Cost of products and services 959 1,151 (17%) Research and development 275 307 (10%) Selling, general and administrative 536 580 (8%) Total costs and expenses 1,770 2,038 (13%) Loss from operations (34) (432) 92% Other income (expense), net 19 3 N/M Loss before taxes (15) (429) 97% Benefit for taxes (13) (154) (92%) Pro forma net loss $ (2) $ (275) 99% Pro forma net loss per share: Basic $ (0.00) $ (0.60) Diluted $ (0.00) $ (0.60) Average shares used in computing pro forma net loss per share: Basic 467 460 Diluted 467 460 The above pro forma condensed consolidated statement of operations has been adjusted to exclude the following one-time and non-recurring items and reconcile to GAAP net (loss) earnings: Net (loss) earnings per GAAP $ (236) $ 197 Pro forma adjustments: Goodwill 79 93 Other intangibles 13 13 Restructuring 256 154 Other asset impairment 6 8 Discontinued operations 1 (1,068) Gain relating to securities - 6 Other 6 - Adjustment for income taxes (127) 322 Pro forma net loss $ (2) $ (275) We provide pro forma financial information to help the reader better understand our operating results. This information is not in accordance with, or an alternative for, generally accepted accounting principles and may be different from the pro forma information provided by other companies.
CONDENSED CONSOLIDATED BALANCE SHEET (In millions, except par value and share amounts) October 31, October 31, 2002 2001 ASSETS Current assets: Cash and cash equivalents $ 1,844 $ 1,170 Accounts receivable, net 1,118 977 Inventory 1,184 1,491 Net investment in lease receivable 1 237 Current deferred tax assets 462 494 Other current assets 271 430 Total current assets 4,880 4,799 Property, plant and equipment, net 1,579 1,848 Goodwill and other intangible assets, net 685 1,070 Long-term deferred tax assets 635 10 Other assets 436 259 Total assets $ 8,215 $ 7,986 LIABILITIES AND STOCKHOLDERS EQUITY Current liabilities: Accounts payable $ 305 $ 392 Employee compensation and benefits 662 576 Deferred revenue 244 279 Income and other taxes payable 325 173 Other accrued liabilities 574 582 Total current liabilities 2,110 2,002 Senior convertible debentures 1,150 - Other liabilities 325 325 Total liabilities 3,585 2,327 Commitments and contingencies - - Stockholders equity: Preferred stock; $0.01 par value; 125 million shares authorized; none issued and outstanding - - Common stock; $0.01 par value; 2 billion shares authorized; 467 million shares at October 31, 2002 and 461 million shares at October 31, 2001 issued and outstanding 5 5 Additional paid-in capital 4,872 4,723 Retained (deficit) earnings (101) 931 Accumulated comprehensive loss (146) - Total stockholders equity 4,630 5,659 Total liabilities and stockholders equity $ 8,215 $ 7,986
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (In millions) Twelve months Three months ended ended October 31, October 31, 2002 2002 Cash flows from operating activities: Loss from continuing operations $ (1,022) $ (235) Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization 735 187 Inventory-related charges 40 8 Deferred taxes (675) (678) Asset impairment charges 159 129 Retirement plans curtailment gain (19) - Net gain on divestitures and sale of assets (18) (6) Changes in assets and liabilities: Accounts receivable (137) (241) Inventory 278 96 Accounts payable (88) (62) US pension trust fund contribution (82) (6) Employee compensation and benefits 99 100 Income taxes 137 598 Other current assets and liabilities 61 (66) Other long-term assets and liabilities (73) 14 Net cash used in operating activities *: (605) (162) Cash flows from investing activities: Investments in property, plant and equipment (301) (88) Proceeds from net investment in lease receivable 237 - Purchase of equity investments (23) (8) Acquisitions, net of cash acquired (15) (15) Proceeds from dispositions 31 5 Net cash used in investing activities: (71) (106) Cash flows from financing activities: Issuance of senior convertible debentures, net of issuance costs 1,123 - Issuance of common stock under employee stock plans 141 10 Net payments to notes payable and short-term borrowings (1) (2) Net cash provided by financing activities: 1,263 8 Net cash provided by (used in) discontinued operations 87 (1) Change in cash and cash equivalents 674 (261) Cash and cash equivalents at beginning of period 1,170 2,105 Cash and cash equivalents at end of period $ 1,844 $ 1,844 * Cash payments for restructuring included in operating activities: 235 51
TEST AND MEASUREMENT INFORMATION (In millions, except percent changes) Three months Three months Three months ended ended ended October 31, October 31, Yr vs.yr July 31, Sequential 2002 2001 % change 2002 % change Orders $ 824 $ 676 22% $ 802 3% Net Revenue $ 967 $ 936 3% $ 715 35% Loss from operations $ (111) $ (355) 69% $ (279) 60% Twelve months Twelve months ended ended October 31, October 31, Yr vs.yr 2002 2001 % change Orders $ 3,294 $ 4,021 (18%) Net Revenue $ 3,318 $ 5,432 (39%).. Loss from operations $ (837) $ (120) (598%) Q4 FY02 vs Q3 FY02 BY MARKET SEGMENT Orders Net Revenue Q4 FY02 Sequential % of Q4 FY02 Sequential % of $ Amount % change Segment $ Amount % change Segment Communications test $ 357 10% 43% $ 408 40% 42% Semiconductor test 115 (36%) 14% 184 15% 19% General purpose test 352 18% 43% 375 43% 39% $ 824 3% 100% $ 967 35% 100% Q4 FY02 vs Q4 FY01 BY MARKET SEGMENT Orders Net Revenue Q4 FY02 Yr vs.yr % of Q4 FY02 Yr vs.yr % of $ Amount % change Segment $ Amount % change Segment Communications test $ 357 26% 43% $ 408 28% 42% Semiconductor test 115 92% 14% 184 84% 19% General purpose test 352 6% 43% 375 (28%) 39% $ 824 22% 100% $ 967 3% 100% Loss from operations reflect the results of our reportable segments under Agilent's management reporting system. These results are not necessarily a depiction that is in conformity with accounting principles generally accepted in the United States. In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months. Historical amounts were reclassified to conform with current period presentation.
SEMICONDUCTOR PRODUCTS INFORMATION (In millions, except percent changes) Three months Three months Three months ended ended ended October 31, October 31, Yr vs.yr July 31, Sequential 2002 2001 % change 2002 % change Orders $ 363 $ 260 40% $ 383 (5%) Net Revenue $ 471 $ 383 23% $ 390 21% Earnings (loss) from operations $ 32 $ (115) 128% $ (24) 233% Twelve months Twelve months ended ended October 31, October 31, Yr vs.yr 2002 2001 % change Orders $ 1,568 1,290 22% Net Revenue $ 1,559 1,850 (16%) Loss from operations $ (68) (177) 62% Q4 FY02 vs Q3 FY02 BY MARKET SEGMENT Orders Net Revenue Q4 FY02 Sequential % of Q4 FY02 Sequential % of $ Amount % change Segment $ Amount % change Segment Networking $ 123 7% 34% $ 130 0% 28% Personal systems 240 (10%) 66% 341 31% 72% $ 363 (5%) 100% $ 471 21% 100% Q4 FY02 vs Q4 FY01 BY MARKET SEGMENT Orders Net Revenue Q4 FY02 Yr vs.yr % of Q4 FY02 Yr vs.yr % of $ Amount % change Segment $ Amount % change Segment Networking $ 123 13% 34% $ 130 (24%) 28% Personal systems 240 59% 66% 341 61% 72% $ 363 40% 100% $ 471 23% 100% Earnings (loss) from operations reflect the results of our reportable segments under Agilent's management reporting system. These results are not necessarily a depiction that is in conformity with accounting principles generally accepted in the United States. In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months. Historical amounts were reclassified to conform with current period presentation.
LIFE SCIENCES AND CHEMICAL ANALYSIS INFORMATION (In millions, except percent changes) Three months Three months Three months ended ended ended October 31, October 31, Yr vs.yr July 31, Sequential 2002 2001 % change 2002 % change Orders $ 308 $ 285 8% $ 271 14% Net Revenue $ 298 $ 287 4% $ 286 4% Earnings from operations $ 45 $ 38 18% $ 42 7% Twelve months Twelve months ended ended October 31, October 31, Yr vs.yr 2002 2001 % change Orders $ 1,151 $ 1,103 4% Net Revenue $ 1,133 $ 1,114 2% Earnings from operations $ 150 $ 91 65% Earnings from operations reflect the results of our reportable segments under Agilent's management reporting system. These results are not necessarily a depiction that is in conformity with accounting principles generally accepted in the United States. In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months. Historical amounts were reclassified to conform with current period presentation.
ORDERS AND NET REVENUE FROM CONTINUING OPERATIONS BY GEOGRAPHY For The Three Months Ended October 31 ORDERS Percent (In millions) Inc/(Dec) 2002 2001 USD Local Currency Americas $ 629 $ 572 10% 10% Europe 296 237 25% 19% Asia Pacific 570 412 38% 38% NET REVENUE Total $ 1,495 $ 1,221 22% 20% Americas $ 713 $ 704 1% Europe 320 331 (3%) Asia Pacific 703 571 23% Total $ 1,736 $ 1,606 8% In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.
ORDERS AND NET REVENUE FROM CONTINUING OPERATIONS BY GEOGRAPHY For The Twelve Months Ended October 31 ORDERS (In millions) Percent decrease 2002 2001 USD Local Currency Americas $ 2,539 $ 2,782 (9%) (9%) Europe 1,154 1,401 (18%) (20%) Asia Pacific 2,320 2,231 4% 6% NET REVENUE Total $ 6,013 $ 6,414 (6%) (6%) Americas $ 2,553 $ 3,913 (35%) Europe 1,154 1,772 (35%) Asia Pacific 2,303 2,711 (15%) Total $ 6,010 $ 8,396 (28%) In general, recorded orders represent firm purchase commitments from our customers with established terms and conditions for products and services that will be delivered within six months.